Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Seaman

Showing results (181-190 of 415) with videos related to

Pageof 42
Sort By:
Biorxiv : the Preprint Server for Biology|November 26, 2025
Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challengeUrjeet S Khanwalkar, Jennifer Fields, Joshua A Wiener, et al.
Nature Microbiology|May 11, 2026
Diverse paths to broadly neutralizing antibody escape among HIV-1 strainsAlex C Stabell, Songhee Lee, Debby J Park, et al.
Transplantation|September 27, 1996
Portal vein thrombosis and stenosis in pediatric liver transplantationJ M Millis, D S Seaman, J B Piper, et al.
The Journal of General Virology|August 6, 2010
Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: clade C infection results in a stronger and broader humoral immune response than clade B infectionHanna Dreja, Eithne O'Sullivan, Corinna Pade, et al.
Vaccine|August 8, 2009
Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectorsSampa Santra, Yue Sun, Birgit Korioth-Schmitz, et al.
Vaccine|December 29, 2010
Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulationMartin P Cranage, Carol A Fraser, Alethea Cope, et al.
Plos Pathogens|December 3, 2010
Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41Charles Sabin, Davide Corti, Victor Buzon, et al.
Journal of Virology|June 26, 2015
Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFLRajnish Kumar, Ruimin Pan, Chitra Upadhyay, et al.
Cell Reports|May 31, 2018
Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers PolyreactivityJulie Prigent, Annaëlle Jarossay, Cyril Planchais, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2022
Engineering pan-HIV-1 neutralization potency through multispecific antibody avidityEdurne Rujas, Hong Cui, Jonathan Burnie, et al.
Pageof 42

Showing results (181-190 of 415) with videos related to

Sort By:
Pageof 42
Biorxiv : the Preprint Server for Biology|November 26, 2025
Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challengeUrjeet S Khanwalkar, Jennifer Fields, Joshua A Wiener, et al.
Nature Microbiology|May 11, 2026
Diverse paths to broadly neutralizing antibody escape among HIV-1 strainsAlex C Stabell, Songhee Lee, Debby J Park, et al.
Transplantation|September 27, 1996
Portal vein thrombosis and stenosis in pediatric liver transplantationJ M Millis, D S Seaman, J B Piper, et al.
The Journal of General Virology|August 6, 2010
Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: clade C infection results in a stronger and broader humoral immune response than clade B infectionHanna Dreja, Eithne O'Sullivan, Corinna Pade, et al.
Vaccine|August 8, 2009
Heterologous prime/boost immunizations of rhesus monkeys using chimpanzee adenovirus vectorsSampa Santra, Yue Sun, Birgit Korioth-Schmitz, et al.
Vaccine|December 29, 2010
Antibody responses after intravaginal immunisation with trimeric HIV-1 CN54 clade C gp140 in Carbopol gel are augmented by systemic priming or boosting with an adjuvanted formulationMartin P Cranage, Carol A Fraser, Alethea Cope, et al.
Plos Pathogens|December 3, 2010
Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41Charles Sabin, Davide Corti, Victor Buzon, et al.
Journal of Virology|June 26, 2015
Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFLRajnish Kumar, Ruimin Pan, Chitra Upadhyay, et al.
Cell Reports|May 31, 2018
Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers PolyreactivityJulie Prigent, Annaëlle Jarossay, Cyril Planchais, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2022
Engineering pan-HIV-1 neutralization potency through multispecific antibody avidityEdurne Rujas, Hong Cui, Jonathan Burnie, et al.
Pageof 42